Roivant | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (2)

Latest Posts

About This Stock More About This Stock
Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
Article By: Invezz
Wednesday, September 27, 2023 4:05 AM EDT
Roivant Sciences has 12 drugs in its pipeline. The company’s Immunovant subsidiary reported strong results for its drug. Roivant is in talks with Roche to sell its Chron’s disease for $7 billion.
In this article: ROIV Also: IMVT
Read
Roivant Sciences: Is Vivek Ramaswamy’s Biotech Stock A Buy?
Article By: Invezz
Sunday, September 10, 2023 6:09 AM EDT
Roivant Sciences stock price has entered a major bull run as investors remain optimistic about the company’s future. The shares surged to a high of $12.67 on Friday, reaching its highest level since December 2021.
In this article: ROIV
Read

Latest Tweets for $ROIV

No tweets yet!

PARTNER HEADLINES